The Grünenthal Foundation was founded in 2012 and integrated the Grünenthal hardship initiative which had already existed since 2011. The goal of the Foundation is to permanently improve the life situation of thalidomide-affected individuals. We support people around the world as long as the person in question is recognised by the Contergan Foundation or certain other institutions such as the UK Thalidomide Trust which use comparable criteria in the recognition of injury caused by thalidomide.
Continuous dialogue with those affected and their representatives is important to us to ensure that we can provide support where it is most urgently needed.
Please feel free to get in touch with us.